R. P. Weitzel

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIMS/HYPOTHESIS Non-Fc-binding Anti CD3 antibody has proven successful in reverting diabetes in the non-obese diabetes mouse model of type 1 diabetes and limited efficacy has been observed in human clinical trials. We hypothesized that addition of rapamycin, an mTOR inhibitor capable of inducing operational tolerance in allogeneic bone marrow(More)
  • 1